Study found that Lactobacillus rhamnosus GCC-3 culture can improve intestinal and liver health and antiviral immunity of zebrafish
Researchers from the Aquatic Microbiology and Feed Innovation Team at the Feed Institute of the Chinese Academy of Agricultural Sciences have made a significant discovery regarding the benefits of incorporating Lactobacillus rhamnosus GCC-3 culture into the diet of zebrafish. Their findings indicate that this dietary addition can enhance the overall health of the zebrafish's liver and intestines while bolstering their antiviral immunity. This breakthrough has the potential to contribute to the advancement of aquaculture by offering valuable insights into areas such as liver lipid metabolism, liver and intestinal tissue health, and viral disease prevention. The research results have been published in the journal "Fish and Shellfish Immunology."
Probiotics have been utilized to effectively regulate the early interactions between gut microorganisms and their host, which, in turn, has long-lasting benefits in establishing and enhancing the digestive tract's immune function and overall production performance. However, the efficacy of probiotics in bolstering fish resistance to other infectious diseases, particularly viral infections, has remained a relatively unexplored area of study.
This particular study has unveiled some promising outcomes. The inclusion of 1% GCC-3 culture in the diets of zebrafish led to significant improvements in their growth performance. It also resulted in a marked reduction in the expression of pro-inflammatory genes like IL-1β in the livers of zebrafish and an upregulation of hypoxia-inducible factor (Hif-1α) in their intestines, along with an increase in the expression of tight junction proteins (ZO-1α and ZO-1β).
Bacterial sequencing data indicated that the group of zebrafish fed with 1% GCC-3 culture exhibited a substantial reduction in the abundance of Proteobacteria and an enrichment of Firmicutes in their intestinal flora.
Furthermore, when these zebrafish were challenged with Carp Spring Viremia Virus (SVCV), they displayed a higher survival rate compared to the control group. Additionally, their type I interferon antiviral immune response was significantly elevated. This study demonstrates the substantial probiotic benefits of incorporating 1% GCC-3 culture into the zebrafish diet, positively impacting their intestinal and liver health, as well as their antiviral immunity. These findings have the potential to pave the way for further research and development of GCC-3 culture as a functional feed additive in fish farming. The research was supported by funding from the National Natural Science Foundation of China.
2026-07-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
VIV Health & Nutrition Asia 2026 Brings Together Innovation and Business Across the Animal Feed and Health Industry
-
VIV Health & Nutrition Asia 2026 Brings Together Innovation and Business Across the Animal Feed and Health Industry
-
European Commission Greenlights Innovative Feed Additives for Livestock Nutrition
-
EU Declares Safety of Nematophilic Fungus NCIMB 30336 Feed Additive for Herbivores
-
EU Greenlights Corynebacterium glutamicum KCCM 80185-Derived L-Isoleucine as Universal Animal Feed Supplement
-
EU evaluates the safety and effectiveness of sweet fennel oil as a feed additive for dogs and cats and bitter fennel oil as a feed additive for all animals
-
The EU proposes to revise the maximum residue limits for triclopyr in animal products
-
Eu to assess the environmental safety of Deczulil as a feed additive for laying hens and pheasants
-
The EU assesses the safety and efficacy of feed additives consisting of sodium and potassium ferrocyanide for all animals
Recommend Reading
-
PPG Q2 Net Sales Reach $4.2 Billion Net Profit Down 9 Percent as Organic Growth Offsets Sector Headwinds
-
Covestro Q2 Sales Down 8.4 Percent EBITDA Drops to €270 Million Outlook Cut Amid Tariff Shock and Price Squeeze
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
Olin Reports $1.3 Million Q2 Net Loss Sales Hit $1.76 Billion Stock Buyback Continues
-
Short-term correction in lithium carbonate, medium to long-term logic remains unchanged
-
This Week's Caustic Soda Prices Remain Firm (8.18-8.22)
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin
-
This week, styrene prices rose slightly (8.18-8.22) in China
-
Cabot Launches 95F Conductive Additive to Boost Lithium Battery Life for Energy Storage Demands Soar